At this year's conference, TransCelerate and representatives from its member companies, including Amgen, Merck, and Pfizer, will participate in seven sessions addressing topics such as data collection ...
A cryopreserved umbilical cord tissue connective tissue allograft, processed and distributed by Regenative Labs, was incorporated as part of the protocol. Umbilical cord tissue is a naturally ...
In a new publication, researchers from the German Center for Diabetes Research (DZD) and the University of Medicine ...
Glaucoma diagnostics and imaging technology represent a rapidly evolving area at the intersection of clinical ophthalmology, biomedical engineering, and ...
Clinical studies designed to support FDA clearance and planned commercial launch into the world’s largest drug screening market Company ...
Truveta is a real-world intelligence company transforming medical science with unprecedented data and AI. Truveta powers breakthrough discoveries, accelerates regulatory-grade evidence, and unlocks ...
With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.
New peer-reviewed research demonstrates breakthrough in early detection of adverse pregnancy outcomes for Medicaid patients, ...
DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As global healthcare regulations tighten and patient ...
Personalized clinical research is gaining momentum as the limitations of population-based studies in guiding individual ...
A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...
New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures The research assesses how protocol design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results